Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer.
about
Skin problems and EGFR-tyrosine kinase inhibitorAntibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis.A studentized permutation test for three-arm trials in the 'gold standard' design.Treatment strategies of epidermal growth factor receptor inhibitor-induced skin toxicities: pre-emptive or reactive?Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid TumorsThe safety of afatinib for the treatment of non-small cell lung cancer.Dermatologic Reactions to Targeted Therapy: A Focus on Epidermal Growth Factor Receptor Inhibitors and Nursing Care.Management of epidermal growth factor receptor tyrosine kinase inhibitor-related cutaneous and gastrointestinal toxicities.Minocycline Improves the Efficacy of EGFR Inhibitor Therapy: A Hypothesis.Role of Systemic Antibiotics in Preventing Epidermal Growth Factor Receptor: Tyrosine Kinase Inhibitors-induced Skin ToxicitiesSkin communicates what we deeply feel: antibiotic prophylactic treatment to reduce epidermal growth factor receptor inhibitors induced rash in lung cancer (the Pan Canadian rash trial).Preventing or treating anti-EGFR related skin rash with antibiotics?Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer.AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer.A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer.A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies.Taking it in the chin: vitamin K1 for the prevention of acneiform rash.Management Strategies for Adverse Events Associated With EGFR TKIs in Non-Small Cell Lung Cancer.Team Management of Skin Rash Associated with Use of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
P2860
Q28069454-39B8211E-4004-4FE5-B1C7-7BA580A50837Q36026706-72E1E993-42D6-48FC-BA12-D6ADFB7CDC85Q36196674-4D680AEA-2934-47BB-95B3-7FF0D26FC6FDQ37227195-E028F12D-4129-4E3A-A5AD-3EE1E34300B5Q37496672-ACD8FB37-C836-4231-B9A0-BECE9E0A79A6Q38955468-980489B4-D02A-4272-A7B7-FDEA6BA1F90DQ39131525-38B0424B-2C73-429C-B7D9-F37187F9ED5CQ39278689-02986DEE-6A17-4545-B4A5-5984E7E73E72Q40456709-EA6889E1-6859-464C-BE57-DD3EDF64D13FQ41835826-F1F16095-E2CA-4C3B-9155-FA4137479A9FQ42398728-3422DF03-5428-4479-A671-C5AC8093717DQ42398733-567E8CD9-F3CE-4514-A698-102AB4190076Q47102325-D8ECCA31-A9FA-4B4B-9564-BEE4C88C9E89Q47138214-708917C5-84A1-4D1D-9B11-BE44CC74AF70Q47727248-7183EBEE-B517-479C-AAD3-847C05D6E68BQ50108934-F11FF1A2-3786-40FE-AEF5-C1615147C4B2Q52642629-2E9106B2-5FEF-4D9C-AE31-D29AE3F396E2Q54166640-8DE93678-3D3C-4A9B-9DBC-4F05B0B17E7CQ57052257-870BDF93-5B88-4014-9517-FF7650B52968
P2860
Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pan Canadian Rash Trial: A Ran ...... s With Metastatic Lung Cancer.
@en
Pan Canadian Rash Trial: A Ran ...... s With Metastatic Lung Cancer.
@nl
type
label
Pan Canadian Rash Trial: A Ran ...... s With Metastatic Lung Cancer.
@en
Pan Canadian Rash Trial: A Ran ...... s With Metastatic Lung Cancer.
@nl
prefLabel
Pan Canadian Rash Trial: A Ran ...... s With Metastatic Lung Cancer.
@en
Pan Canadian Rash Trial: A Ran ...... s With Metastatic Lung Cancer.
@nl
P2093
P356
P1476
Pan Canadian Rash Trial: A Ran ...... s With Metastatic Lung Cancer.
@en
P2093
Barbara Melosky
Christopher W Lee
Desiree Hao
Helen Anderson
Janessa J Laskin
Natasha B Leighl
Nevin Murray
Quincy Chu
Robert Winston
P304
P356
10.1200/JCO.2015.62.3918
P407
P577
2015-11-16T00:00:00Z